The year in cardiovascular medicine 2021: dyslipidaemia

Tokgozoglu, L., Orringer, C., Ginsberg, H. N., & Catapano, A. L. (2022). The year in cardiovascular medicine 2021: dyslipidaemia. European Heart Journal, 43(8), 807–817. https://doi.org/10.1093/eurheartj/ehab875
Authors:
Lale Tokgozoglu
Carl Orringer
Henry N. Ginsberg
Alberico L. Catapano
Affiliated Authors:
Henry N. Ginsberg
Columbia Affiliation:
Subjects:
Cardiovascular Agents (MeSH)
Cardiovascular Diseases (MeSH)
Dyslipidemias (MeSH)
Author Keywords:
antisense
crispr
cardiovascular diseases
ldl-c. triglycerides
lipids
lp(a)
nucleic acid therapeutics
pcsk9 inhibitors
rna interference
statins
ldl-c
triglycerides
elink
Publication Type:
Article
Unique ID:
10.1093/eurheartj/ehab875
PMID:
34974612
DOI:
10.1093/eurheartj/ehab875
Journal:
European Heart Journal
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: